麻豆传媒

Experts talk about long-term data and the importance of infection prophylaxis

Alarming mental health challenges among young cancer survivors, especially males, demand action

Benefit seen in all prespecified subgroups, including high-risk patients

New standard of care for patients in first remission?

Two-thirds of phase II patients had a complete response at 12 weeks of treatment

Nearly half of women with unusual or nonreportable cfDNA-sequencing results had cancer

Benefit shown in trial of patients flagged for high risk of cardiotoxicity

Health news and commentary gathered by 麻豆传媒 staff

Improvements seen in pain, neuropathy, and cognitive function

May become "treatment of choice" over brentuximab vedotin for all disease stages

Likelihood of severe maternal morbidity more than 20 times higher versus the general population

News, features, and commentary about cancer-related issues

Regimen tops best historical response rate with chemoimmunotherapy in this setting

Incidence almost identical to that with standard cancer treatment in randomized trials